About Autosomal dominant secondary polycythemia
Autosomal dominant secondary polycythemia is a rare disease catalogued by Orphanet (ORPHA:247511). It is associated with the EPO, EGLN1, EPAS1 genes. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Autosomal dominant secondary polycythemia trials.
Search ClinicalTrials.gov for "Autosomal dominant secondary polycythemia" or filter by Orphanet code ORPHA:247511 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Autosomal dominant secondary polycythemia trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Autosomal dominant secondary polycythemia. Updated daily.